NPS Pharmaceuticals (NPSP)
Create an AlertNPS Pharmaceuticals Liabilities:
192.71M for March 31, 2013NPS Pharmaceuticals Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 192.71M |
| Dec. 31, 2012 | 205.75M |
| Sept. 30, 2012 | 212.21M |
| June 30, 2012 | 232.18M |
| March 31, 2012 | 237.70M |
| Dec. 31, 2011 | 260.10M |
| Sept. 30, 2011 | 276.00M |
| June 30, 2011 | 280.59M |
| March 31, 2011 | 317.94M |
| Dec. 31, 2010 | 384.18M |
| Sept. 30, 2010 | 378.65M |
| June 30, 2010 | 373.30M |
| March 31, 2010 | 367.93M |
| Dec. 31, 2009 | 382.39M |
| Sept. 30, 2009 | 377.02M |
| June 30, 2009 | 364.79M |
| March 31, 2009 | 426.00M |
| Dec. 31, 2008 | 418.69M |
| Sept. 30, 2008 | 409.80M |
| June 30, 2008 | 384.91M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
NPSP Liabilities Benchmarks
| Companies | |
|---|---|
| Alexion Pharmaceuticals | 595.83M |
| Elan | 1.163B |
| Vertex Pharmaceuticals | 1.646B |
NPSP Liabilities Rankings
| Overall |
70th percentile 4903 of 16773 |
| Sector |
48th percentile 732 of 1408 in Healthcare |
| Industry |
34th percentile 295 of 453 in Biotechnology |
NPSP Liabilities Range, Past 5 Years
| Minimum | 192.71M | Mar 2013 |
| Maximum | 426.00M | Mar 2009 |
| Average | 324.14M |
